表面活性イオン液体ベースのマイクロエムルションの物理化学的特徴付け,ルチンの皮膚経送量を強化するために
Mina Tanigawa1, Chew Ben Kiat1, Yukihiro Ono2
1Division of Applied Chemistry, Graduate School of Engineering, Sojo University, 4-22-1 Ikeda, Nishi-ku, Kumamoto 860-0082, Japan.
Chemical & pharmaceutical bulletin
|February 23, 2026
まとめ
この研究では,深層エウテクティック溶剤と表面活性イオン性液体を使用して新しいマイクロエムルションを開発し,トランスダーマルルーチン投与を強化しました. 特定のマイクロエムルション製剤を使用すると,ルーチンによる皮膚の浸透性が著しく増加しました.
科学分野:
- マテリアルサイエンス 材料科学
- 医薬品科学 医薬品科学とは
- 化学工学は化学工学というものです.
背景:
- 効率的な皮膚経由薬剤投与は依然として課題です.
- フラボノイドであるルチンは,治療的可能性はあるが,皮膚への浸透は薄い.
- マイクロエムルション (ME) は,薬物の投与のための有望な手段を提供します.
研究 の 目的:
- ルーチンを効率的に皮膚経由で投与するための新しいマイクロエムルション (ME) システムを開発する.
- ME製剤における深層エウテクティック溶剤 (DES) と表面活性イオン性液体 (SAIL) の役割を調査する.
- 開発されたMEの構造的特徴と皮膚の浸透性を評価する.
主な方法:
- コリン塩化物/ポリエチレングリコール (PEG) 200をDESとして,1-アルキル-3-メチルミダゾリウムブロミド (Cn mimBr) をSAILとして使用したMEの製剤.
- 小角X線散射 (SAXS) と伝送電子顕微鏡 (TEM) を用いた構造的特徴化.
- 従来の油中の水 (W/O) MEsとSAILベースのMEsによるルーチン皮膚の透かし性のインビトロ評価.
主要な成果:
- C10ミームBrとC12ミームBrを持つMEは円筒状の構造を示し,C16ミームBrは球状の構造を形成した.
- SAILベースのMEは,ルチンの皮膚浸透性が著しく向上したことを実証しました (約. 通常のW/O MEsと比較して6.8倍高い).
- SAILにおけるアルキル鎖の長さの選択は,ME構造とルチンの透過性に影響した.
結論:
- SAILベースのマイクロエムルションは,皮膚経由のルーチン投与を強化するための効果的なキャリアです.
- SAILによって決定されるMEの構造的形態は,薬物浸透において重要な役割を果たします.
- この製剤戦略は,先端の皮膚経由薬剤投与システムの開発に有望である.
関連する概念動画
Bioavailability Enhancement: Drug Permeability Enhancement
263
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
263
Bioavailability Enhancement: Drug Solubility Enhancement
328
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
328
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
613
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
613
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.8K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.8K
Factors Influencing Drug Absorption: Physicochemical Parameters
1.1K
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
1.1K
Transdermal Drug Delivery Systems
56
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
56


